Skandinaviska Enskilda Banken (SEB)’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-90,241
Closed -$739K 904
2022
Q2
$739K Buy
90,241
+35,555
+65% +$304K 0.01% 754
2022
Q1
$434K Sell
54,686
-27,146
-33% -$234K ﹤0.01% 849
2021
Q4
$759K Hold
81,832
﹤0.01% 803
2021
Q3
$1.29M Sell
81,832
-2,017
-2% -$36.2K 0.01% 744
2021
Q2
$1.81M Buy
83,849
+2,354
+3% +$47.6K 0.01% 690
2021
Q1
$1.65M Sell
81,495
-8,642
-10% -$171K 0.01% 713
2020
Q4
$1.61M Buy
90,137
+19,431
+27% +$285K 0.01% 709
2020
Q3
$822K Buy
70,706
+69,110
+4,330% +$803K 0.01% 768
2020
Q2
$15K Buy
+1,596
New +$14.3K ﹤0.01% 1026

Other funds holding AXGN

Skandinaviska Enskilda Banken (SEB)'s AXGN Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Axogen (AXGN) in Q3 2022, closing a stake of 90,241 shares — an estimated $739K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AXGN in Q2 2020 and held it in 9 quarters. The position peaked at $1.81M in Q2 2021. 126 funds tracked by Wall St. Rank hold AXGN as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Axogen position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 90,241 Axogen shares in Q3 2022, an estimated $739K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Axogen in Q2 2020 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Axogen position peaked at $1.81M in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Axogen as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.